Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Baricitinib is not very effective for severe alopecia areata.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Brentuximab vedotin chemotherapy can cause long-term hair loss and emotional distress.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Topical Valproate is safe for human skin and unlikely to cause irritation.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Abrocitinib may effectively treat stubborn alopecia universalis.

Baricitinib improved hair loss and arthritis in a lupus patient.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

A new method improves betulin delivery and shows promise in cancer treatment.

The inhibitor affects androgen metabolism but not ovarian function.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.